Elsevier

Atherosclerosis

Volume 213, Issue 2, December 2010, Pages 598-603
Atherosclerosis

Physicians’ perception, knowledge and awareness of cardiovascular risk factors and adherence to prevention guidelines: The PERCRO-DOC survey

https://doi.org/10.1016/j.atherosclerosis.2010.09.014Get rights and content

Abstract

Background

Cardiovascular diseases (CVD) are the major cause of premature death in the world. This study was designed to examine the physicians’ knowledge and perception of CVD risk factors and perceived implementation of CVD prevention guidelines as well as barriers to their implementation.

Methods

A questionnaire survey by face-to-face interviews was performed among 1382 randomly selected physicians (general practitioners/family medicine specialists, internists and cardiologists) from different regions of Croatia.

Results

Most physicians believe that guidelines are useful but only 56.9% are really using some guidelines. 40.2% favour Joint European guidelines. More primary care physicians use their own personal experience in prevention while internists and cardiologists tend more to use the guidelines. 80.6% believe that they treat their patients with dyslipidemia well but only 53.3% knew the LDL-cholesterol goal value for high-risk patients and only 56.2% knew which HDL-cholesterol level is the marker of increased risk. Hypertension was perceived as the most important risk factor, particularly by primary care physicians, while cardiologists tend to favour diabetes. Although most physicians considered the lack of financial resources as the main barrier in CVD prevention, at the same time most of them believe that it could primarily be improved by better patient education.

Conclusions

Although most physicians support the guidelines use, only half of them use them and in average their knowledge of guidelines is not satisfactory. This is, together with the lack of time and finances and perceived lack of patients’ awareness, probably one of the main causes why they do not manage risk factors better.

Introduction

Cardiovascular diseases (CVD) are the leading cause of death and the disease burden worldwide. In Europe they cause 43% of all the deaths before the age of 75 in women and 38% of deaths in men, not only in high- but more and more in low- and middle-income countries as well [1]. This means that one in 3 of all men and two in 5 of all women die from these diseases before the age of 75. Most important among these diseases are coronary heart disease (CHD), acute myocardial infarction (AMI) and ischaemic stroke. Over the past 25 years death rates from CVD have been falling in most northern and western European countries (precisely EU members before 2004 or “old EU “) but rising rapidly in most central and especially eastern European countries [2], [3]. However, the decrease in mortality in mentioned countries has not been accompanied by reductions in CVD morbidity.

It is well known that CVD are all product of multiple risk factors, the most important being dyslipidemias (particularly increased blood concentrations of total and LDL-cholesterol and triglycerides and decreased HDL-cholesterol), elevated blood pressure, smoking, overweight and obesity, diabetes and metabolic syndrome [4]. Numerous studies have confirmed that almost all of these risk factors are modifiable and therefore most of CVD are preventable [5], [6].

However, despite clear evidence of the benefits of modifiable risk factors management, especially in patients with CVD and other high-risk patients who are defined as the highest priority for prevention by all versions of Joint European guidelines on CVD prevention [4], [7], [8], [9] as well as by all the other non-European guidelines [10], [11], the results of surveys performed for monitoring the trends in risk factor management are quite disappointing [12]. Recently published results of the EUROASPIRE studies designed to follow these trends during the last 10 years in different European countries have also shown a collective medical failure to achieve the risk factor targets according to the guidelines in this priority group. According to them about one-fifth of CHD patients still continue to smoke, their body weight continues to increase as well as the prevalence of central obesity, the prevalence of diabetes also continues to increase and the therapeutic control of diabetes remains poor while the blood pressure management shows no improvement despite the increases in prescriptions for all classes of anti-hypertensive medications except for calcium channel blockers [13], [14]. Only the management of dyslipidemia has substantially improved driven by the widespread use of statins but significant number of patients on lipid-lowering therapy is still not achieving the treatment goals according to the guidelines [15].

The objective of this survey was to explore the physicians’ perception of CVD risk factors and their adherence to different international prevention guidelines with the idea to try to explain the inadequate and delayed translation of scientific evidence as presented in guidelines into clinical practice. Since only few studies on physicians’ knowledge and perceptions on CVD risk factors and guidelines implementation have been published so far, we have performed the following survey on the attitudes of the general practitioners/family doctors, internists and cardiologists with regard to their knowledge of guidelines and perception of CVD risk factors as well as to assess their treatment practices and the impact of their knowledge on their treatment practices – PERception of CVD risk factors in CROatia – DOCtors (PERCRO-DOC survey).

Section snippets

Study population and questionnaire

We conducted a cross-sectional questionnaire survey of primary care physicians defined as general practitioners and/or family doctors (GP), and specialists—internists, and cardiologists in Croatia, a country with 11 799 physicians (1753 GPs and 927 specialists in GP, 987 general internists, 203 cardiologists) and 4 400 000 inhabitants [16]. Physicians were randomly recruited using national physicians registry and professional societies’ directories. The country was divided into five geo-economic

Results

1382 physicians consented to answer the questionnaire and their answers were included in this survey. 618 (44.7%) were GPs, 312 (22.6%) family medicine specialists, 165 (11.9%) cardiologists and 213 (15.4%) internists. Since 74 (5.4%) did not answer the question about their speciality status, their answers were not included in comparing knowledge and attitudes by specialities. For further analysis GPs and family medicine specialists were taken together as primary practice physicians.

Most of

Discussion

This is the largest survey on physician awareness of risk factors and adherence to CVD prevention guidelines performed so far. Only three similar surveys were performed previously: on 754 randomly selected GPs and family doctors from five European countries by telephone interviews in 2001—REACT survey [17], on 664 general practitioners and internists by mailed questionnaire in the city of Muenster, Germany in 2002 [18] and a market research survey on 220 primary care physicians and

Conclusion

An important and encouraging observation from this survey is that the majority of physicians support the concept of preventive cardiology and guidelines use. However, this survey also showed the reality that only half of them use guidelines in everyday practice and too many of them do not know, for example, the target values for lipids according to the guidelines. It seems that most physicians would like to have simpler, more user-friendly guidelines evidence-based upon independent research in

References (30)

  • Ž. Reiner

    Cardiovascular prevention under the burden of cardiovascular disease: what should be done and what could be done

    Fundam Clin Pharmacol

    (2008)
  • Reiner Ž, Muačević-Katanec D. Impact of treating dyslipidemia on cardiovascular events. In: Mancini M, Ordovas JM,...
  • D. Wood et al.

    Prevention of coronary heart disease in clinical practice. Recommendations of the Second joint task force of European and other societies on coronary prevention

    Eur Heart J

    (1998)
  • G. De Backer et al.

    European guidelines on cardiovascular disease prevention in clinical practice

    Eur J Cardiovasc Prev Rehabil

    (2003)
  • Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Final report

    Circulation

    (2002)
  • Cited by (115)

    • Lipid-lowering therapy use in primary and secondary care in Central and Eastern Europe: DA VINCI observational study

      2021, Atherosclerosis
      Citation Excerpt :

      When comparing results between different countries, the types of specialists in the participating sites of each country should be considered. Specialists in internal medicine or neurologists may have had limited knowledge of LDL-C goals in the dyslipidaemia guidelines compared with lipidologists or cardiologists [19]. As such, depending on the clinicians’ speciality, there may have been bias in the observed treatment patterns of LLT, consequently impacting LDL-C goal attainment.

    View all citing articles on Scopus
    View full text